Progyny Inc (NAS:PGNY)
$ 23.261 0.35 (1.53%) Market Cap: 2.10 Bil Enterprise Value: 1.82 Bil PE Ratio: 36.30 PB Ratio: 4.55 GF Score: 80/100

Progyny Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 07:50PM GMT
Release Date Price: $41.96 (+4.51%)
Sarah Elizabeth James
Barclays Bank PLC, Research Division - Research Analyst

Thank you, everyone, so much for coming. My name is Sarah James. I'm the emerging health care delivery model and Provider Analyst at Barclays, and I'm really thrilled to have with us here Progyny. It's our top pick and really has been mine since your IPO. And we have CFO, Mark Livingston with us today and also CEO, Peter Anevski.

Questions & Answers

Sarah Elizabeth James;Peter Anevski
Barclays Bank PLC, Research Division - Research Analyst;Progyny, Inc. -

And I think we're going to start off with some questions about the macro because I always find that's where the debate kind of starts with fertility insurance. You guys don't know. Progyny is one of the leading providers of fertility insurance in the U.S.

So how do you think about the TAM developing over the next 5 years? And then within that, what does the breakdown shift look like between people that can't get access and have no coverage versus employer-sponsored and self-pay?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot